abstract |
The present invention relates to a compound of formula (I) and stereisomers, pharmaceutically acceptable salts, solvates, or tautomer thereof, wherein L 1 , A, X 1 , X 2 , X 3 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 9 , R 10 , m, n are as defined in the specification, and their uses as RET, SRC and/or BTK kinase inhibitors for the treatment of diseases such as cancer. |